Semaglutide activates only GLP-1 receptors (not GIP), which produces slightly less dramatic weight loss on average but may come with fewer side effects for certain individuals
They are not licensed by the MHRA for human administration
For instance, it has been demonstrated that NR supplementation is safe up to 3000 mg daily, with readouts reported for NAD + levels, mitochondrial function, and clinical phenotypes measured in several trials 246,310,311,312,313
Samanta et al., 2020)
Een substudie toonde bij mensen met diabetes type 2 een gewichtsverlies van 16,8% n een significante verbetering van de bloedsuikerwaarden (HbA1c-daling van circa 2 procentpunt) en een vermindering van levervet met meer dan 80%
These medications are only reimbursed when used for their FDAapproved uses, such as type 2 diabetes, not obesity